SciTech to Present at Biotech Showcase 2020 in San Francisco
Michimich.com/10039509

GROSSE POINTE, Mich. - Michimich -- SciTech Development announced that it has scheduled a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. Earle Holsapple, President will be presenting SciTech's innovative ST-001 nanoFenretinide technology at Biotech Showcase as follows:

Date: Monday, January 13, 2020
Time: 11:15 AM (PST)
Room: Franciscan B
Venue: Hilton San Francisco Union Square Hotel, 333 O'Farrell Street, San Francisco, CA

Qualified investors can register to attend Biotech Showcase for free.

ST-001 nanoFenretinide is a small-molecule cancer drug comprised of nanoparticle sized fenretinide in a patented combination with carefully selected phospholipids. SciTech's product pipeline includes nanoFenretinide formulations for the treatment for several cancer indications. The FDA has granted Orphan Drug Status for ST-001 nanoFenretinide in the treatment of two types of NHL: peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL).

More on Michimich.com

• Maccabi USA Men's Basketball Announces New Head Coach For 21st Maccabiah
• Michigan: Meridian Road bridge repairs over I-96 underway in Ingham County
• Michigan: Attorney General Nessel Urges Senate to Pass Legislation to Ensure Relief for all Federal Student Loan Borrowers Impacted by COVID-19 Pandemic
• Michigan: Attorney General Nessel Announces Appointment of Oceana County Public Administrator
• Michigan: MDOT virtual meeting to give update on 2020-21 M-28 project in Munising

About SciTech Development

SciTech Development, LLC is a clinical stage oncology drug company currently bringing to market a proven cancer drug for diseases with otherwise limited therapeutic options. SciTech Development is headquartered in the Metropolitan Detroit Michigan Area with laboratories at the Sinai Hospital BioIncubator in Baltimore Maryland. Information regarding SciTech's nano formulation technology and oncology drug product ST-001 nanoFenretinide is available from SciTech Development, LLC by calling (313) 938-5517 or at https://www.scitechdevelopment.com/ . You can follow SciTech Development on Twitter at @SciTechUSA

About Biotech Showcase

Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.

More on Michimich.com

• Clarity Gold Reported 2.32 oz/t Au - Sent Crews to Three High Grade Gold Properties in BC
• Doctor Develops Personalized Solution to COVID-19 Threat
• Amaze Properties LLC Is Looking To Buy Another Property In Metro Detroit Michigan
• iEducation Group Launches Global Accredited, One-to-One Virtual School
• Andrew Carnegie Global Capital Announces a $20M Fintech Venture with Braintree in the Coming Year

Forward-Looking Information

This press release and linked information contains forward-looking statements, including information about management's view of SciTech Development LLC ("the Company"), future expectations, plans and prospects. Any statements made in this release and linked information other than those of historical fact, about an action, event or development, are forward-looking statements. The forward-looking statements included in this press release and linked information are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by SciTech Development LLC.